Lovo®
Automated Cell Processing System

PROCESS FAST. MAXIMIZE CONTROL.

Only Lovo delivers automated, functionally closed cell processing through spinning membrane filtration.

Interested in learning more about our other Cell Processing System?

Lovo - Automated Cell Processing System 360 View

For Laboratory Use Only

360 Icon

Designed with you in mind.

Hear the people who designed Lovo talk about how its technology, design, and performance were driven by the needs of labs like yours.

Applications

Achieve
flexibility with a

single instrument.

Each cell therapy manufacturing process is unique. Lovo's flexibility supports multiple applications, at any stage of your operation.

Design

Count on a platform instrument that
scales with you.

Whether you're working with millions or billions of cells, in 10mL or 22L, Lovo adapts with you to easily scale your process, from Phase 1 through Commercialization.

Technology

Spinning membrane filtration is fast, adaptable, and non‑fouling.

You don't need to trade cell recovery with washout efficiency. Lovo’s spinning membrane filtration allows you to process a wide range of cell volumes and concentrations quickly, while maximizing recovery and cell viability.

Lovo and DXT®

Access secure procedure data. Anytime, anywhere.

DXT Data Management System for use with the Lovo Cell Processing System, is an open architecture software platform supported by our team of networking specialists. Lovo and DXT support 21 CFR Part 11 compliance.

Joint Venture​

Cell therapy manufacturing that’s simple and scalable.

Lovo seamlessly integrates into the ScaleReady cell therapy manufacturing platform, enabling you to rapidly generate and package life-saving cell therapies at scale. ScaleReady is currently supporting account management and application support for customers in the United States, Canada, Europe, and Israel.

ScaleReady

Stay Informed.

Sign up below to receive the latest Lovo news and updates.

See Us In Action.

Come see what Lovo is all about. We’ll walk you through the features and arrange for a demonstration.

CAR-TCR Summit
September 17-20, 2024
Boston, MA

Meeting on the Mesa
October 7-9, 2024
Phoenix, AZ

ESGCT Annual Congress
October 22-25, 2024
La Nuvola, Rome, Italy

Society for Immunotherapy of Cancer (sitc)
November 6-10, 2024
Houston, TX

Document

Need more info?

Download it here.

Lovo Brochure | PDF

Fresenius Kabi Product Catalog | PDF

 

Immunomagnetic Selection Prep Diagram | PDF

The Lovo Cell Processing System is for laboratory use only and may not be used for direct transfusion. Appropriate regulatory clearance is required by the user for clinical use.

For applications requiring regulatory clearance or approval, Users may request required Lovo technical documentation from Fresenius Kabi to support their submission.

Refer to the Lovo Cell Processing System Operator’s Manual, DXT Administrator’s Guide and DXT User’s Guide for a complete list of warnings and precautions associated with the use these products.

References

1-4Data on File at Fresenius Kabi USA

About Fresenius Kabi USA

Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition.

Our products are used to help care for critically and chronically ill patients. The people of Fresenius Kabi are driven by a common purpose to put lifesaving medicines and technologies in the hands of people who care for patients, and to find answers to the challenges they face.